Evidence map›Paper›PMID 29736594›Full record

Observational studyPharmaceutical research2018

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population.

Thibault Vallet, Emilie Belissa, Sandra Laribe-Caget, Alain Chevallier, François-Xavier Chedhomme, Patrick Leglise, Matthieu Piccoli, Hugues Michelon, Vanessa Bloch, Sylvie Meaume and 22 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Pharmaceutical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 9 institutions in 2 countries.

Thibault ValletClinSearch, 110 Avenue Pierre Brossolette, 92240, Malakoff, France.
Emilie BelissaDépartement Recherche et Développement Pharmaceutique, Agence Générale des Equipements et Produits de Santé (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Sandra Laribe-CagetHôpital Rothschild, Groupe Hospitalier Universitaire Est Parisien, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Alain ChevallierHôpital Broca, Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
François-Xavier ChedhommeHôpital Broca, Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Patrick LegliseHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Matthieu PiccoliHôpital Broca, Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Hugues MichelonHôpital Sainte Périne, Groupe Hospitalier Universitaire Paris Ile-de-France Ouest, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France.
Vanessa BlochHôpital Fernand Widal, Groupe Hospitalier Universitaire Saint-Louis - Lariboisière - Fernand-Widal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Sylvie MeaumeHôpital Rothschild, Groupe Hospitalier Universitaire Est Parisien, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Anne-Sophie GrancherHôpital Rothschild, Groupe Hospitalier Universitaire Est Parisien, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Nathalie BachalatHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Imad BoulaichHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Fattima AbdallahHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Maite RabusHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Jean-Paul RwabihamaHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Annie-Claude RibemontHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Celia LachuerHôpital Joffre Dupuytren, Groupe Hospitalier Universitaire Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), Draveil, France.
Ines PerquyHôpital Broca, Groupe Hospitalier Universitaire Paris Centre, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
Laurent LechowskiHôpital Sainte Périne, Groupe Hospitalier Universitaire Paris Ile-de-France Ouest, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France.
Anne DelahayeHôpital Sainte Périne, Groupe Hospitalier Universitaire Paris Ile-de-France Ouest, Assistance Publique- Hôpitaux de Paris (AP-HP), Paris, France.
Mathieu DepoissonHôpital Vaugirard, Groupe Hospitalier Universitaire Paris Ouest, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Yann OrvenHôpital Vaugirard, Groupe Hospitalier Universitaire Paris Ouest, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Caroline GuinotHôpital Fernand Widal, Groupe Hospitalier Universitaire Saint-Louis - Lariboisière - Fernand-Widal, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Stephane GibaudCentre Hospitalier de l'Ouest Vosgien, Neufchâteau, France.
Corinne MichelHôpital René Muret, Groupe Hospitalier Universitaire Paris Seine-Saint-Denis, Assistance Publique-Hôpitaux de Paris (AP-HP), Sevran, France.
Abdel MahiouHôpital René Muret, Groupe Hospitalier Universitaire Paris Seine-Saint-Denis, Assistance Publique-Hôpitaux de Paris (AP-HP), Sevran, France.
Sid-Ahmed BelbachirHôpital René Muret, Groupe Hospitalier Universitaire Paris Seine-Saint-Denis, Assistance Publique-Hôpitaux de Paris (AP-HP), Sevran, France.
Jean-Hugues TrouvinDépartement Recherche et Développement Pharmaceutique, Agence Générale des Equipements et Produits de Santé (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Amelie Dufaÿ-WojcickiDépartement Recherche et Développement Pharmaceutique, Agence Générale des Equipements et Produits de Santé (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Vincent BoudyDépartement Recherche et Développement Pharmaceutique, Agence Générale des Equipements et Produits de Santé (AGEPS), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Fabrice RuizClinSearch, 110 Avenue Pierre Brossolette, 92240, Malakoff, France. fabrice.ruiz@clinsearch.net.ORCID http://orcid.org/0000-0001-9167-0189
Assistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire Henri-Mondor · FRHôpital Cochin · FRDélégation Paris 5 · FRSorbonne Université · FRAgence France-Presse · FRCentre Hospitalier Vétérinaire Frégis · FRLaboratoire Conception de Produits et Innovation · FRPierre Fabre (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMedicine acceptability, which is of the utmost importance for vulnerable patients' adherence, is driven by both user and product characteristics. Herein, a novel multivariate approach integrating the many aspects of acceptability is used to discriminate positively and negatively accepted medicines in the older population.

methodsAn observational study was carried out in eight hospitals and eight nursing homes to collect a large set of real-life data on medicines uses in older patients (≥65 years). Mapping and clustering explored these multiple observational measures and summarised the main information into an intelligible reference framework. Resampling statistics were used to validate the model's reliability.

resultsA three-dimensional map and two clusters defining acceptability profiles, as positive or negative, emerged from the 1079 evaluations. Factors of interest (medicines, user features…) were positioned on the map at the barycentre of their evaluations and assigned to an acceptability profile. Focusing on patients' ability to swallow, we have highlighted the tool's efficacy in demonstrating the impact of user features on medicine acceptability.

conclusionsThis multivariate approach provides a relevant judgement criterion for this multi-dimensional concept. Facilitating the choice of the most appropriate dosage form to achieve optimal acceptability in a targeted population, this tool is of real potential to improve clinical decisions.

Indexed as

Decision Support TechniquesDrug DesignMedication AdherencePolypharmacyAgedAged, 80 and overAgingCross-Sectional StudiesFemaleHumansMaleProspective StudiesRandom Allocationdrug formulationelderlymedicine acceptabilitymultivariate analysisswallowability

Identifiers

PMID29736594
PMCPMC5938307
OpenAlexW2800520563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.